FDA Inspection 1070943 — Central California Blood Center
The FDA completed an inspection of Central California Blood Center on Oct 11, 2018 in Fresno, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 11, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fresno, CA (United States)